LA VILLA, GIORGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.241
EU - Europa 1.986
AS - Asia 357
AF - Africa 9
SA - Sud America 1
Totale 6.594
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.228
SE - Svezia 466
IE - Irlanda 401
PL - Polonia 262
UA - Ucraina 256
HK - Hong Kong 194
IT - Italia 194
DE - Germania 168
FI - Finlandia 103
CN - Cina 67
GB - Regno Unito 54
CH - Svizzera 49
TR - Turchia 35
FR - Francia 21
JO - Giordania 21
IN - India 17
CA - Canada 12
SG - Singapore 11
RU - Federazione Russa 6
SC - Seychelles 6
KR - Corea 4
NL - Olanda 4
VN - Vietnam 4
BE - Belgio 2
EG - Egitto 2
IR - Iran 2
TH - Thailandia 2
BR - Brasile 1
MU - Mauritius 1
MX - Messico 1
Totale 6.594
Salva come PNG Salva come JPEG
Città #
Fairfield 624
Chandler 427
Jacksonville 414
Dublin 401
Woodbridge 322
Ashburn 290
Cambridge 283
Seattle 270
Warsaw 262
Wilmington 237
Houston 236
Hong Kong 102
Princeton 102
Ann Arbor 93
Boardman 82
Boston 74
Buffalo 70
Lawrence 56
Bern 49
Altamura 46
Beijing 44
Medford 43
San Diego 40
Izmir 27
Milan 19
Norwalk 19
Florence 18
Auburn Hills 13
Falls Church 13
Shanghai 13
Bremen 12
Dearborn 11
Frankfurt Am Main 10
Los Angeles 10
Singapore 10
Andover 8
New York 8
Verona 8
Salerno 7
Toronto 7
Hillsboro 6
Washington 6
Dong Ket 4
Pune 4
Laurel 3
London 3
Riardo 3
Brescia 2
Brussels 2
Cairo 2
Cedar Hill 2
Kolkata 2
Kunming 2
Naaldwijk 2
Nakhon Ratchasima 2
Nanjing 2
New Delhi 2
Padova 2
San Mateo 2
West Jordan 2
Yuseong-gu 2
Agliana 1
Ardabil 1
Ashford 1
Atlanta 1
Bari 1
Bologna 1
Comeana 1
Detroit 1
Dover 1
Genoa 1
Guangzhou 1
Hamburg 1
Hanover 1
Hefei 1
Helsinki 1
Hull 1
Huntsville 1
Kirkland 1
Levis 1
Mérida 1
Napanee 1
Ningbo 1
Northampton 1
Omsk 1
Phoenix 1
Redmond 1
Redwood City 1
Sabará 1
Shenyang 1
Stanford 1
Tappahannock 1
Xian 1
Totale 4.869
Salva come PNG Salva come JPEG
Nome #
Spiral computed tomography versus ultrasound in the follow up of cirrhotic patients previously treated for hepatocellular carcinoma: a prospective study 217
THAD in biliary duct disease 203
Renal hemodynamic and natriuretic effects of human atrial natriuretic factor infusion in cirrhosis with ascites. 113
Plasma levels of brain natriuretic peptide in patients with cirrhosis. 106
Long-term albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial. 97
Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation 92
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial. 92
Altered cardiovascular responsiveness to active tilting in nonalcoholic cirrhosis. 92
Prevention of severe toxic liver injury and oxidative stress in MCP-1-deficient mice 91
Torasemide in the treatment of patients with cirrhosis and ascites. 91
High pretransplant serum levels of CXCL10/IP-10 are related to increased risk of renal allograft failure 91
"Inapparent" hepatitis B virus infection and hepatitis C virus replication in alcoholic subjects with and without liver disease 91
High CXCL10 expression in rejected kidneys and predictive role of pretransplant serum CXCL10 for acute rejection and chronic allograft nephropathy. 88
Ascites and hepatorenal syndrome 87
T(14;18) translocation in chronic hepatitis C virus infection 85
Effects of low-dose captopril on renal hemodynamics and function in patients with cirrhosis of the liver. 84
Systemic hemodynamics and renal function in cirrhotic patients during plasma volume expansion. 82
Elevated plasma levels of urotensin II do not correlate with systemic haemodynamics in patients with cirrhosis. 82
Pharmacokinetics and pharmacodynamics of torasemide and furosemide in patients with diuretic resistant ascites. 81
Functional renal alterations in chronic liver diseases. 81
Blunted natriuretic response to low-dose brain natriuretic peptide infusion in nonazotemic cirrhotic patients with ascites and avid sodium retention. 81
Effects of rhein on renal arachidonic acid metabolism and renal function in patients with congestive heart failure. 80
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial 80
Cardiovascular and renal function in normotensive and hypertensive patients with compensated cirrhosis: effects of posture. 79
Pathogenesis and management of the hepatorenal syndrome. 79
COMBINED PRESENCE OF HCVRNA SEQUENCES AND T(14;18) (q32;q21) TRANSLOCATION IN PBMC FROM PATIENTS WITH CHRONIC HCV INFECTION. 78
Pathogenesis and treatment of ascites in hepatic cirrhosis. 77
ALBUMIN IMPROVES RESPONSE TO DIURETICS IN DECOMPENSATED CIRRHOTIC PATIENTS. 77
Renal effects of atrial natriuretic peptide during dopa-decarboxylase inhibition in patients with essential hypertension. 77
Loop diuretic therapy in liver cirrhosis with ascites 76
Cardiovascular effects of canrenone in patients with preascitic cirrhosis 76
Increased plasma carbon monoxide in patients with viral cirrhosis and hyperdynamic circulation. 76
Hepato-systemic gradient of carbon monoxide in cirrhosis. 76
Uveitis in autoimmune hepatitis: a case report. 75
In vivo evidence that endogenous dopamine modulates sympathetic activity in man. 75
Ascites and hepatorenal syndrome during cirrhosis: two entities or the continuation of the same complication? 74
Pathogenesis and treatment of ascites in hepatic cirrhosis. 74
Comparison of the effects of torasemide and furosemide in nonazotemic cirrhotic patients with ascites: a randomized, double-blind study. 73
Analysis of HCV persistence in patients with sustained virological response 72
Altered renal and platelet arachidonic acid metabolism in cirrhosis. 72
Cardiovascular and renal function in normotensive and hypertensive patients with compensated cirrhosis: effects of posture. 72
Liver-kidney pathophysiological interrelationships in liver diseases. 71
Impaired cardiovascular autonomic response to passive tilting in cirrhosis with ascites. 70
CARDIOVASCULAR EFFECTS OF PARATHYROID HORMONE: A STUDY IN HEALTHY SUBJECTS AND NORMOTENSIVE PATIENTS WITH MILD PRIMARY HYPERPARATHYROIDISM 70
Urinary endothelin-1 excretion is enhanced by low-dose infusion of brain natriuretic peptide in normal humans. 70
Hemodynamic, renal and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis 69
Effects of clonidine on power spectral analysis of heart rate variability in mild essential hypertension. 69
Combined presence of HCVRNA sequences and t(14;18) (q32;q21) translocation in PBMC from patients with chronic HCV infection 69
Vascular reserve in the lower limbs of cirrhotic patients: a duplex Doppler ultrasound study. 68
Multiple immune disorders in unrecognized celiac disease: a case report 68
Systemic hemodynamics and renal function during brain natriuretic peptide infusion in patients with essential hypertension. 67
Systemic haemodynamics, renal and platelet function during chronic propranolol ADMINISTRATION IN PATIENTS WITH COMPENSATED CIRRHOSIS 67
Is the use of albumin of value in the treatment of ascites in cirrhosis? The case in favour 66
Hepatorenal syndrome and its treatment today. 66
Dopamine and sympathoadrenal activity in man. 65
Is the use of albumin of value in the treatment of ascites in cirrhosis? The case in favour. 65
Intrarenal thromboxane A2 generation reduces the furosemide-induced sodium and water diuresis in cirrhosis with ascites 62
Increased production of nitric oxide by neutrophils and monocytes from cirrhotic patients with ascites and hyperdynamic circulation. 62
Effects of acute clonidine administration on power spectral analysis of heart rate variability in healthy humans. 61
Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis 60
Effects of dietary supplementation with arachidonic acid on platelet and renal function in patients with cirrhosis. 60
Cardiac and renal response to posture in cirrhotics with and without essential hypertension 60
Renal impairement in chronic liver diseases with and without cholestasis 58
Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis. 57
Reduced platelet thromboxane A2 production as a possible cause of defective platelet aggregation in cirrhosis. 55
Arachidonic acid derivatives and renal function in liver cirrhosis. 55
Hemodynamic alterations in liver cirrhosis. 54
Transient Hepatic Attenuation Differences - Pictorial Essay 53
Behaviour of sustained responders to anti-HCV treatment: may HCV infection be eradicated? 52
Bcl-2 rearranged B cell clones in chronic HCV infection: a possible factor negatively influencing the virological response to treatment 49
Comportamento dell'infezione da HCV in pazienti trapiantati per HCC complicante una cirrosi HCV-correlata 48
The kinin system and other vasoactive substances in chronic liver disease. 48
Cerebral autoregulation in patients with cirrhosis and ascites. A transcranial Doppler study. 47
[Viral liver cirrhosis: natural course, pathogenesis and clinical implications of the complications] 46
Long course and prognostic factors of virus-induced cirrhosis of the liver. 45
Purification of PGE2 in the urine of cirrhotic patients: comparison of three chromatographic techniques. 45
Prevalence of bcl-2 rearrangement in hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. 45
Low-dose C-natriuretic peptide does not affect cardiac and renal function in man 44
Vasoactive factors in decompensated cirrhosis. Effect of acute plasma expansion. 43
Hemodynamic derangement and cardiac dysfunction in cirrhosis. 43
Hepatitis C virus infction of mononuclear cells from peripheral blood and liver infiltrates in chronically infected patients. 41
The rational use of albumin in patients with cirrhosis and ascites. A Delphi study for the attainment of a consensus on prescribing standards. 40
Effects of OKY 046, a thromboxane-sinthase inhibitor, on renal function in non-azotemic cirrhotic patients with ascites 40
Vasoactive factors in decompensated cirrhosis. Effect of acute plasma expansion. 40
Pathogenetic factors and clinical elements in ascites and hepatorenal syndrome during liver cirrhosis. 36
[Determination of prostaglandin E2 and F2 alpha in the urine of cirrhotic patients: comparison of 3 different chromatographic methods] 36
Prevalence of bcl-2 rearrangement in hepatitis C virus-related mixed cryoglobulinemia with or without complicating B-cell lymphoma 35
Refractory ascites: definition, pathogenesis and treatment. 35
La Cirrosi Epatica Virus-correlata: Storia Naturale, patogenesi e implicazioni cliniche dellew complicanze. 34
Prevalence of bcl-2 recombination in hepatitis C virus-related mixed cryoglobulinemia with or without complicating B-cell lymphoma. 33
Il fegato: fisiopatologia, clinica, terapia 31
Il Fegato: Fisiopatologia, Clinica, Terapia 31
Prevalenza della ricombinazione Bcl-2 in pazienti con crioglobulinemia mista HCV correlata complicata o meno da linfoma.. 30
Renal Impairment In Chronic Liver-Diseases With And Without Cholestasis. 30
Problemi nutrizionali e terapia dietetica del cirrotico 28
Virological analysis of the healthy HCV carrier state: prognostic factors and HCV persistence in non viraemic subjects 28
pathogenetic factors of renal dysfuntion in chronic liver disease 26
Presence of BCL-2 rearranged B-cell clones in chronic HCV infection may negatively influence virological response to treatment 26
Persistence of HCV in hepatic and extrahepatic cells from asymptomatic non viremic chronic anti-HCV carriers. 26
Prevalence of bcl-2 recombination in hepatitis C virus-related mixed cryoglobulinemia with or without complicating B-cell lymphoma. 25
Totale 6.568
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.217
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.217
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019633 0 0 0 0 0 0 0 0 0 117 280 236
2019/20201.496 119 127 24 153 142 206 160 200 136 82 128 19
2020/2021962 77 42 105 83 46 146 23 92 70 126 68 84
2021/2022636 11 77 20 21 20 32 21 35 31 23 162 183
2022/20231.746 163 191 93 126 177 321 241 113 186 14 58 63
2023/2024471 25 76 102 28 36 69 14 112 6 3 0 0
Totale 6.605